Batch management plays a crucial role in the life sciences industry, ensuring quality, compliance, and traceability. Learn ...

We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Kontra Investment Xchange’s Substack by ...

IN AN EFFORT to produce graduates with chemical engineering and chemistry skillsets, Nanyang Technological University (NTU) ...

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

In the increasingly complex healthcare realm, a regular flow of drug introductions offers potential ... A collaborative drug ...

Lilly filed a lawsuit Nov. 14 against HHS head Xavier Becerra and the Health Resources and Services Administration for blocking a plan to change its 340B program from immediate discounts to offering ...

Hypera S.A. Sponsored ADR ( (HYPMY) ) has released its Q3 earnings. Here is a breakdown of the information Hypera S.A. Sponsored ADR presented ...

United Therapeutics is a leader in PAH treatments, with Tyvaso being the primary revenue driver. Check out why I rate UTHR ...

More than a few companies that did well in the past are out of favor with investors. And that could spell opportunity.

The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.

Q3 2024 Results Earnings Conference Call November 13, 2024 4:30 PM ET. Company Participants. William Febbo - Chief Executive Officer Edward St ...

Reported total revenue of $10.3 million and GAAP Net Income of $0.6 million, or $0.02 per diluted shareEntered into an asset purchase agreement ...